Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Done by : Mohannad AL.shibani clinical pharmacist intern Supervised by: Dr. Muna Fliflan 1 1 1 FILE NO. :248758 CASE ROOM NO. :451 D 86 years Saudi male,70 KG, presented to ER. On (16/10/2008) C/O fever, productive cough, and not eating well since 2 day back. Patient was discharged from medical department 1 month back (13/9/2008) on case of “”drug induced hypoglycemia”” and all his medication was stopped .then he was well until 7 day back when he started to have fever 39°C . He was seen in polyclinic and discharge on antibiotic and cough syrup but was not given to patient . 2 days back patient was lethargic with fever ,decrease in appetite and weakness. he is not eating well according to his son and he took him to private polyclinic and found to be febrile and dehydrated with blood glucose 420 mg/dl. They gave him IVF ,insulin and they told him to take patient to big hospital. 1 1 2 Case cont….. Past medical history: I. II. III. 1 Type 2 DM from HTN Old CVA 1 3 Case cont….. Past medication: I. II. III. IV. V. 1 ASA 81 mg po OD Omeprazole 20 mg po OD Glibenclamide D/C on 13/9 Metformin HCTZ 1 4 Case cont….. 1 Diagnosis: chest infection and dehydration Vital signs: Temp. 38.5°C Bp. 161/83 mm/Hg pulse 70/min RR. 22 /min 1 5 Case cont….. Physical examination: 1 16/10/2008 Skin & extremities: not pale or jaundice, sleepy , difficult in hearing Eyes , ears & neck: normal Chest wall & lungs: clean with equal air entry bilaterally, spontaneous breathing & yellowish sputum Cardiovascular: S1 + S2 + 0 Abdomen : soft , no organomegally Bone & joints : skin pealing & dry bed sores Mental status : conscious 1 6 Progress note: Date:16/10 Plan: 1) Urine analysis 3) 4 points BS monitoring 4) low salt & DM diet 6) ½ NS 60cc /hr IV. 8) klaccid 250 mg BID PO 10) omeprazole 20mg OD PO 12) capoten 12.5mg BID PO 2) blood c/s, urine c/s & sputum c/s 5) sliding scale for DM 7) PLASIL 10 mg IV. (immediately) 9) ROCEPHINE 1g IV. BID 11) ASA 81mg OD PO ____________________________________________________________________ Date:18/10 Temp. :37.5 Bp. :163/74 RR. :20/min pulse=60 Subjective: patient seeing fine , conscious , but complain of dry bed ulcer and BS. was 258 mg/dl 1 1 7 Progress note: Labs : OSMO.= 265 Alb.= 2.4g/dl ESR.= 45 mm/hr PTT=27.5 (control=31.6) k =2.8 mmol/l Na= 132mmol/ INR= 0.9 PT=10.8 (control=12.5) Urine analysis: urine is light , yellowish & turbid appearance PH=6.5 WBC= 60-70 Hematology analysis: Neut.=9.46 RBC= 3.77 Hct= 31.6% plan: 1 1) 2) 3) 4) Glucose: +ve leucocytes :+ve Bacteria: +++ve WBC=11.56 Hgb=11.00 g/dl Dermatology counseling Add lantus 10 U am. Add fucidin ointment locally BID Add flamazine ointment locally BID 1 8 Progress note: Date:19/10 : Temp. :37.5 Bp. :140/70 RR. :20/min pulse=65 BS.=256 mg/dl ac. CBC: Plan: 1 BUN=25.3 Glu=288 RBC=3.8 Na=130 WBC=11.9 Hgb=11.1 1) lantus 10 U pm. 2)add RI. 8 U SC. TID premeal 3)D/C sliding scale 4)add clexane 40 mg SC. OD 5) dermatolodist seen pt. then change dreesing daily 6) continuous other treatment 1 9 Progress note: Date:20/10: Bp. :139/88 BS.=200 mg/dl pc Subjective: 1)bilateral hand swelling in Rt. Hand 2) febrile vital stable plan: 1 1) increase lantus to 14 U Pm. 2)incourage oral intake 3) D/C IVF. 4) Continuous the treatment 5) C.S.T 6) Repeat chemistry 1 10 Progress note: Date:23/10 Bp. :125/72 BS.=141 mg/dl ac. Subjective: 1)sacral ulcer not improve 2)cough developed during take pre meal 3)lab showed no growth factor on blood after 5 days Lab test: 1) BUN=25.9 2) Na= 131 Plan: 1)insert NGT but his son refused 2) Continuous the treatment 3)C.S.T again 1 1 11 Progress note: Date:27/10 Subjective: C.S.T: Biochemistry: Bp. :130/91 BS.=205 mg/dl ac 1)sacral ulcer still not improve 2)pt. fine, febrile vital stable 1)Urine culture showed Enterococcus spp. 1) BUN=28mg/dl Hematology: 1)RBC=3.85 2)Hgb=11.1 3)Hct=33.2 Plan: 1)increase lantus to 18 U Pm. 2)repeat CBC chemistry 1 1 2)ALB=2.5g/dl 12 Progress note: Bp. :161/89 BS.=88 mg/dl ac Date:28/10: Pt. fine, febrile vital stable Subjective: Decrease RI. to 4 U SC. TID Plan: ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ Date:1/11: Bp. :132/74 BS.=157 mg/dl ac Pt. fine, febrile vital stable 1) increase RI. To 6 U SC. TID premeal 2) increase lantus to 20 U SC. Pm. 13 1 Subjective: Plan: 1 Diabetic follow up DATE 6 am. 16/10 11 am. 6 pm. 11 pm. 275 pc 181 pc 168 pc 17/10 190 ac 168 ac 144 pc 120 pc 18/10 131 ac 258 ac 270 pc 219 pc 19/10 256 ac 118 ac 195 ac 260 pc 20/10 200 pc 321 pc 287 pc 21/10 121 ac 180 pc 134 ac 141 pc 22/10 125 ac 107 ac 205 ac 183 ac 23/10 141 ac 158 ac 253 pc 24/10 168 ac 144 ac 260 pc 25/10 107 ac 326 pc 26/10 222 ac 185 pc 231 ac 240 pc 27/10 205 ac 188 pc 222 ac 247 pc 28/10 88 ac 98 pc 157 ac 151 pc 29/10 120 ac 123 ac 174 ac 158pc 30/10 178 ac 144 pc 177 ac 210 pc 1 31/10 170 ac 206 pc 1 222 pc 228 pc 220 pc 242 pc 14 Discussion Why? Factor associated with switching to insulin: I.younger at diagnosis II.Suffer from more health proplem espicially cardiovascular disease III.Have worse metabolic control IV.HbA1c 1 > 8% 1 15 Discussion cont.. Protocol 1) 2) 3) 4) 1 used when switch to insulin: Single dose of bedtime(long acting) insulin plus daytime sulfonylurea Two injections of intermediate acting insulin Multiple daily injection, combination of short acting and intermediate acting Single dose of bedtime(long acting) insulin plus three times rapid acting insulin before meals 1 16 1 1 17 reference 1 http://grande.nal.usda.gov/ibids/index.ph p?mode2=detail&origin=ibids_references& therow=485719 Wayne A.Kradjan.Handbook of applied therapeuetic.Lippincott Williams and Wilkins.8th ED,2007;Chapter 49,page:65069 1 18